CIPRA.ai
CIPRA.ai is a San Diego-based digital health company that uses Agentic AI and digital twin technology to deliver personalized chronic disease management for hypertension and diabetes, serving patients, healthcare providers, and payers across the U.S. and India.
- Company typePrivate
- Founded2022
- HeadquartersSan Diego, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
CIPRA.ai firmographics
Firmographics- Name
- CIPRA.ai
- Legal name
- CIPRA.ai, Inc.
- Website
- https://cipra.ai
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CIPRA.ai is a San Diego-based digital health company that uses Agentic AI and digital twin technology to deliver personalized chronic disease management for hypertension and diabetes, serving patients, healthcare providers, and payers across the U.S. and India.
- Ownership category
- akta.pro rank
CIPRA.ai industry classification
Industry- Product category
- Digital Health / Chronic Care Management Software
- NAICS
- Software Publishers (513210), Software Publishers (5132)
- SIC
- Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- AI Triage & Clinical Decision Support (CDS) Platforms (HLALAJAD)
- akta.pro secondary industry
- Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection) (HLACAFAE)
Keywords
Where CIPRA.ai is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
CIPRA.ai business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- Subscription-based SaaS: Annual subscription model for patients and healthcare providers accessing the CIPRA.ai chronic condition management platform. Mobile app available on iOS and Android with subscription terms governed by Terms & Conditions agreement.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Subscription-based service for chronic condition management |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
CIPRA.ai product offering
Product offeringCore offering
CIPRA.ai operates an AI-driven digital health platform that creates personalized digital twins of patients to manage and reverse chronic conditions such as hypertension and diabetes. The platform aggregates multimodal data from wearables and health monitors, then uses Agentic AI to deliver hyper-personalized lifestyle recommendations, configurable clinical notifications, and EHR-integrated dashboards for autonomous or clinician-augmented patient engagement.
Product overview
CIPRA.ai is a digital health platform built around AI-powered digital twin technology for managing chronic conditions, primarily hypertension and diabetes. The core platform combines Multimodal Data Fusion, Personal/Population Digital Twin Modeling, Agentic AI Patient Engagement, and a Clinical Dashboard into a unified system. Users interact through the CIPRA.ai Mobile Application (iOS/Android) which connects to wearables (Fitbit, Apple Watch, Garmin) and health monitors (Omron, iHealth). The platform supports multiple deployment models: fully autonomous patient self-management, semi-autonomous with minimal clinician oversight, or clinician-directed with health coaches. India Operations represents a localized variant with regional healthcare partnerships.
Differentiator
Problem solved
Functional benefit
Products and services
- CIPRA.ai Platform AI-driven digital health platform that creates personalized digital twins to manage chronic conditions like hypertension and diabetes, integrating data from wearables and health monitors to deliver precise, proactive care recommendations. Targeted at health systems, providers, payers, and patients.
- CIPRA.ai Mobile Application Interactive mobile app available on iOS and Android that enables individual patients to record meals via text or speech, track progress, and receive personalized weekly lifestyle recommendations for blood pressure and glucose management. Integrates with Apple Watch, Fitbit, Garmin, and Bluetooth blood-pressure/glucose monitors.
- CIPRA.ai India Operations Localized version of the CIPRA.ai platform serving the Indian market through partnerships with RxDx Healthcare and 2050 Healthcare, with innovation support from ARTPARK @IISc Bangalore. Supports chronic disease management for Indian patients and clinicians.
Quantifiable outcome
- Sustained patient engagement rates observed in clinical trials and pilot deployments
- +5 more outcomes
Companies that use CIPRA.ai
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
CIPRA.ai technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability6 records
Feature6 records
CIPRA.ai partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered flagship, core and innovation.
- TechstarsflagshipTechstars Healthcare Accelerator powered by Permanente Medicine Mid-Atlantic selected CIPRA.ai as one of 10 startups from approximately 800 applicants to participate in a three-month program providing access to Kaiser Permanente's physician network and healthcare innovation ecosystem. Demo day showcased AI-powered platforms for chronic disease management.
- Kaiser Permanente Mid-AtlanticcoreHealthcare provider partner supporting Techstars Healthcare Accelerator and providing physician network access. Dr. Katie Ryder (Co-Chief, Adult & Family Medicine) and Dr. Christopher Thomas (Regional Quality Advisor) serve as physician advisors to CIPRA.ai.
- UC San Diego HealthcoreHealthcare partner collaborating on AI-powered chronic condition management platform. Origin of six-year R&D and clinical trials through UCSD Connected Health Program founded by Sujit Dey.
- Neighborhood HealthcarecoreHealthcare partner serving patients with chronic conditions through the CIPRA.ai platform deployment.
- RxDx HealthcarecoreIndia-based healthcare partner for personalized health services addressing chronic conditions. Dr. CMA Belliappa (Chief Medical Officer at RxDx Healthcare) serves as Clinician Advisor to CIPRA.ai.
- 2050 HealthcarecoreIndia-based healthcare partner collaborating with CIPRA.ai for chronic disease management services.
- MuratainnovationInnovation partner working alongside CIPRA.ai on healthcare technology development.
- CarahsoftinnovationInnovation partner listed alongside Techstars and Murata in CIPRA.ai's innovation partner ecosystem.
- ScaleHealthinnovationInnovation partner in CIPRA.ai's ecosystem for healthcare technology collaboration.
- ARTPARK @ IISc BangalorecoreInnovation partner and healthcare initiative collaborator at Indian Institute of Science. Dr. Bhaskar Rajakumar serves as Program Director - Healthcare at ARTPARK and Clinician Advisor to CIPRA.ai, leading healthcare innovation focused on One Health and climate change impact on health.
- SamsunginnovationIndustry partner supporting the six years of R&D and clinical trials at UC San Diego that developed the CIPRA.ai platform.
- TeradatainnovationIndustry partner supporting the R&D and clinical trials at UC San Diego that developed the CIPRA.ai platform.
- Altman Clinical Translational Research InstituteinnovationUC San Diego research institute that supported six years of R&D and clinical trials developing the CIPRA.ai platform.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
CIPRA.ai competitors and assessment
Company assessmentDirect peers
- Hello Heart: Hello Heart is a digital therapeutic focused on hypertension management using a connected BP monitor and an AI-driven mobile app for self-insured employers and payers — closely aligned with CIPRA.ai's hypertension product.
- Omada Health: Omada delivers digital care programs for diabetes prevention, hypertension, and other chronic conditions, sold primarily to payers and employers. It is a direct competitor to CIPRA.ai's payer/employer GTM motion.
- Virta Health: Virta provides AI- and clinician-supported digital programs to reverse type 2 diabetes and other metabolic conditions. Its outcomes-driven chronic-disease reversal model directly overlaps with CIPRA.ai's hypertension and diabetes focus.
- DarioHealth: DarioHealth offers a chronic-condition management platform (diabetes, hypertension, musculoskeletal) combining connected devices, AI, and human coaching, sold to payers and employers — a comparable multi-condition digital therapeutics peer.
- Twin Health: Twin Health uses an AI 'Whole Body Digital Twin' to reverse type 2 diabetes via personalized recommendations from wearable and sensor data — closely analogous to CIPRA.ai's digital-twin architecture and chronic-condition focus.
- Livongo (Teladoc Health): Livongo pioneered AI-driven chronic-condition management (diabetes, hypertension) with connected devices and personalized coaching. It is the most direct comparable to CIPRA.ai's digital-twin approach, though operating at vastly larger scale inside Teladoc Health.
- WellDoc: WellDoc's BlueStar is an FDA-cleared digital therapeutic for type 2 diabetes using AI-driven coaching integrated with blood-glucose data. It is a direct peer on AI-driven diabetes management and clinical workflow integration.
- Vida Health: Vida Health offers a virtual chronic-condition management platform combining AI with human coaches across diabetes, hypertension, and mental health. Comparable to CIPRA.ai on multi-condition chronic care and payer/employer distribution.
- Lark Health: Lark provides an AI-driven chronic-disease prevention and management platform for health plans, with a conversational coaching model. It competes directly with CIPRA.ai on payer contracts and member engagement.
Emerging players
- Better Therapeutics: Better Therapeutics develops prescription digital therapeutics for cardiometabolic conditions, overlapping with CIPRA.ai's hypertension/diabetes focus but targeting FDA-regulated prescription distribution rather than payer subscriptions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
CIPRA.ai social profiles
Digital presenceCIPRA.ai compliance and trust
Trust signalCompliance1 record
CIPRA.ai financial estimates
Financial estimateRevenue estimate
Valuation estimate
CIPRA.ai leadership team
Management profileNumber of profiles
Profiles10 records
CIPRA.ai funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CIPRA.ai M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CIPRA.ai
What does CIPRA.ai do?
CIPRA.ai operates an AI-driven digital health platform that creates personalized digital twins of patients to manage and reverse chronic conditions such as hypertension and diabetes. The platform aggregates multimodal data from wearables and health monitors, then uses Agentic AI to deliver hyper-personalized lifestyle recommendations, configurable clinical notifications, and EHR-integrated dashboards for autonomous or clinician-augmented patient engagement.
Is CIPRA.ai a public or private company?
CIPRA.ai is a private company. It is classified as venture growth investor backed and is currently operating.
When was CIPRA.ai founded?
CIPRA.ai was founded in 2022. It employs 11 to 50 people.
Where is CIPRA.ai based?
CIPRA.ai is headquartered in San Diego, United States, in the North America region.
How does CIPRA.ai make money?
One revenue line is on record: subscription-based SaaS.
Who are CIPRA.ai's main competitors?
Direct peers on record are Hello Heart, Omada Health, Virta Health, DarioHealth, Twin Health, Livongo (Teladoc Health), WellDoc, Vida Health and Lark Health. Better Therapeutics is listed as an emerging player.
Does CIPRA.ai have an API?
No public API is recorded for CIPRA.ai.
What industry is CIPRA.ai in?
CIPRA.ai's product category is Digital Health / Chronic Care Management Software. Its primary akta.pro industry code is HLALAJAD, AI Triage & Clinical Decision Support (CDS) Platforms, with a secondary code of HLACAFAE, Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection). Its NAICS code is 513210 and its SIC code is 7373.